Incidence of heart failure in 6083 elderly hypertensive patients: The Second Australian National Blood Pressure Study (ANBP2)

European Journal of Heart Failure

Volumn 18, Issue 1, 2016, Pages 38-45

  Sahle, Berhe W ^a,b   Owen, Alice J ^a   Krum, Henry ^a   Reid, Christopher M ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b Mekelle University   (Australia)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

Elderly; Heart failure; Hypertension; Incidence; Treatment

Indexed keywords

AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENDER; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBESITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; AUSTRALIA; COMPLICATION; CONTROLLED STUDY; DISEASE COURSE; PATHOPHYSIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE; SURVIVAL ANALYSIS; TIME; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENT;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; AUSTRALIA; COMORBIDITY; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION; INCIDENCE; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROGNOSIS; RISK FACTORS; SEX FACTORS; SMOKING; SURVIVAL ANALYSIS; TIME;

EID: 84954401603     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.427     Document Type: Article

References (33)

1. Zannad F, Briancon S, Juilliere Y, Mertes PM, Villemot JP, Alla F, Virion JM,. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study. J Am Coll Cardiol 1999; 33: 734-742.
2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB,; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014; 129: e28-e292.
3. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ,. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194-202.
4. Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, Jaarsma T, Krum H, Rastogi V, Rohde LE, Samal UC, Shimokawa H, Siswanto BB, Sliwa K, Filippatos G,. Heart failure: preventing disease and death worldwide. ESC Heart Fail 2014; 1: 4-25.
5. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH,. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study. Eur Heart J 2004; 25: 1614-1619.
6. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KL,. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557-1562.
7. Tocci G, Sciarretta S, Volpe M,. Development of heart failure in recent hypertension trials. J Hypertens 2008; 26: 1477-1486.
8. Ramani GV, Uber PA, M. R. Mehra MR,. Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc 2010; 85: 180-195.
9. Bui AL, Horwich TB, Fonarow GC,. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011; 8: 30-41.
10. Meredith PA, Ostergren J,. From hypertension to heart failure-are there better primary prevention strategies? J Renin Angiotensin Aldosterone Syst 2006; 7: 64-73.
11. Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE, Morgan TO, West MJ,; Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348: 583-592.
12. Najafi F, Dobson AJ, Jamrozik K,. Is mortality from heart failure increasing in Australia? An analysis of official data on mortality for 1997-2003. Bull World Health Organ 2006; 84: 722-728.
13. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW, for the Appropriate Blood Pressure Control in Diabetes (ABCD). The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with noninsulin-dependent diabetes and hypertension. N Engl J Med 1998; 338: 645-652.
14. Malacco E, Mancia G, Rappelli A, Menotti A, Zuccaro MS, Coppini A, for the SHELL Investigators. Treatment of isolated systolic hypertension: the Systolic Hypertension in the ELderLy (SHELL) Study results. Blood Press 2003; 12: 160-167.
15. Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ,; CONVINCE Research Group. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003; 289: 2073-2082.
16. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H,; LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For End-point reduction in hypertension (LIFE) study: a randomised trial against atenolol. Lancet 2002; 359: 995-1003.
17. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, de Leeuw PW, Dobovisek J, Jääskivi M, Leonetti G, O'Brien E, Palatini P, Parati G, Rodicio JL, Vanhanen H, Webster J,. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation 2000; 102: 1139-1144.
18. Hansson L, Lindholm LH, Ekbom T, Dahlof B, Lanke J, Schersten B, Wester PO, Hedner T, de Faire U,. Randomised trial of old and new antihypertensive drugs on cardiovascular mortality and morbidity in elderly patients with hypertension: the Swedish Trial in Old Patients with Hypertension-2 (STOP-2). Lancet 1999; 354: 1751-1756.
19. Chowdhury EK, Owen A, Krum H, Wing LM, Nelson MR, Reid CM, Second Australian National Blood Pressure Study Management Committee. Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients. J Hypertens 2014; 32: 525-533.
20. Nichols GA, Hillier TA, Erbey JR, Brown JB,. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 2001; 24: 1614-1619.
21. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D,. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000; 36: 594-599.
22. Chowdhury EK, Owen A, Ademi Z, Krum H, Johnston CI, Wing LM, Nelson MR, Reid CM,; Second Australian National Blood Pressure Study Management Committee. Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure Study. Am J Hypertens 2014; 27: 199-206.
23. Ho KK, Pinsky JL, Kannel WB, Levy D,. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22: 6A-13A.
24. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR,. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
25. Butler J., Primary prevention of heart failure. ISRN Cardiol 2012; 2012: 982417.
26. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS,. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-313.
27. Gopal DM, Kalogeropoulos AP, Georgiopoulou VV, Smith AL, Bauer DC, Newman AB, Kim L, Bibbins-Domingo K, Tindle H, Harris TB, Tang WW, Kritchevsky SB, Butler J,. Cigarette smoking exposure and heart failure risk in older adults: The Health, Aging, and Body Composition Study. Am Heart J 2012; 164 236-142.
28. Suskin N, Sheth T, Negassa A, Yusuf S,. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 37: 1677-1682.
29. Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, Levy D,. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail 2013; 6: 279-286.
30. Weycker D, Nichols GA, O'Keeffe-Rosetti M, John Edelsberg J, M. Khan Z, Kaura S, Gerry Oster G,. Risk-factor clustering and cardiovascular disease risk in hypertensive patients. Am J Hypertens 2007; 20: 599-607.
31. Nelson MR, Alkhateeb AM, Ryan P, Willson K, Gartlan JG, Reid CM, on behalf of the Second Australian National Blood Pressure Management Committee. Physical activity, alcohol and tobacco use and associated cardiovascular morbidity and mortality in the second Australian national blood pressure study cohort. Age Ageing 2010; 39: 112-139.
32. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, White IR, Caulfield MJ, Deanfield JE, Smeeth L, Williams B, Hingorani A, Hemingway H,. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet 2014; 383: 1899-1911.
33. MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ,. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 2000; 102: 1126-1131.